ClinicalTrials.gov
ClinicalTrials.gov Menu

Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00842582
Recruitment Status : Withdrawn (No enrollment. Unable to recruit due to lack of eligible patients.)
First Posted : February 12, 2009
Last Update Posted : November 2, 2016
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
Loyola University

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : March 2011
  Actual Study Completion Date : March 2011